Latest On La Jolla Pharmaceutical Company (LJPC):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-07-11 21:42 EST | News | Innoviva to acquire La Jolla Pharma for $149M including debt | N/A |  |
| 2022-05-17 10:45 EST | News | La Jolla Pharmaceutical GAAP EPS of $0.00 misses by $0.01, revenue of $10.43M misses by $2.67M | N/A | |
| 2022-03-10 01:48 EST | News | La Jolla Pharmaceutical GAAP EPS of $0.11 beats by $0.07, revenue of $12.2M misses by $1.83M | N/A | |
| 2021-11-17 20:35 EST | News | La Jolla Pharmaceutical announces $10M share repurchase plan | N/A | |
| 2021-11-04 11:48 EST | News | La Jolla Pharmaceutical EPS misses by $0.01, misses on revenue | N/A | |
| 2021-09-10 23:57 EST | News | La Jolla Pharmaceutical names Tony Hodges as chief medical officer | N/A | |
| 2021-08-06 05:56 EST | News | La Jolla Pharmaceutical EPS beats by $0.24, beats on revenue | N/A | |
| 2021-07-21 13:54 EST | News | Our Take On La Jolla Pharmaceutical Company | N/A | |
| 2021-05-07 10:58 EST | News | La Jolla Pharmaceutical EPS misses by $0.14, beats on revenue | N/A | |
| 2021-05-07 10:57 EST | News | La Jolla Pharmaceutical shares rise on Q1 topline beat | N/A | |
| 2021-03-10 11:50 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-10 11:50 EST | Analyst Rating | The Analyst Target Price has increased from $9.25 to $9.33. | Buy | |
| 2021-03-09 08:04 EST | Earnings Estimate | An EPS average of -$0.57 is estimated for the 2022 year. | Sell | |
| 2021-03-09 08:04 EST | Earnings Estimate | An EPS average of -$0.28 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-03-09 00:18 EST | News | La Jolla Pharmaceutical EPS beats by $0.21, beats on revenue | N/A | |
| 2021-02-16 07:58 EST | Analyst Rating | The Analyst Target Price has decreased from $11.94 to $9.25. | Neutral | |
| 2021-01-26 07:58 EST | Analyst Rating | The Analyst Target Price has increased from $10.92 to $11.94. | Buy | |
| 2021-01-15 08:02 EST | Analyst Rating | The Analyst Target Price has increased from $10.67 to $10.92. | Buy | |
| 2021-01-12 10:12 EST | News | La Jolla Pharmaceutical stock rallies on exclusive licensing agreement with PAION | N/A | |
| 2021-01-06 16:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 20:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-18 18:02 EST | News | La Jolla Pharmaceutical: Why I'm Skeptical About Giapreza's Sales Potential | N/A | |
| 2020-11-11 12:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-10 18:09 EST | News | La Jolla Pharmaceutical EPS beats by $0.11, beats on revenue | N/A | |
| 2020-11-10 12:27 EST | Earnings Estimate | An EPS average of -$0.63 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-07 16:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-05 17:39 EST | Insider Trade | Michael S Hearne has directly acquired 196 shares and currently holds 365 shares. | Buy | |
| 2020-10-19 21:38 EST | Insider Trade | Michael S Hearne has directly acquired 169 shares and currently holds 169 shares. | Buy | |
| 2020-09-26 13:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-18 09:34 EST | News | La Jolla Pharmaceutical announces CMO departure | N/A | |
| 2020-09-17 17:00 EST | Insider Trade | Lakhmir S Chawla has directly acquired 286 shares and currently holds 13,447 shares. | Buy | |
| 2020-09-17 05:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-10 16:24 EST | Insider Trade | DAVID A RAMSAY has directly acquired 1,000 shares and currently holds 48,000 shares. | Buy | |
| 2020-09-09 19:23 EST | Insider Trade | KEVIN C TANG has acquired 48,296 shares indirectly via LP. | Buy | |
| 2020-09-09 19:23 EST | Insider Trade | KEVIN C TANG has acquired 78,369 shares indirectly via LP. | Buy | |
| 2020-09-09 19:23 EST | Insider Trade | KEVIN C TANG has acquired 84,152 shares indirectly via LP. | Buy | |
| 2020-09-09 19:23 EST | Insider Trade | KEVIN C TANG has acquired 67,552 shares indirectly via LP. | Buy | |
| 2020-09-02 16:42 EST | Insider Trade | Lakhmir S Chawla has directly acquired 550 shares and currently holds 13,161 shares. | Buy | |
| 2020-08-25 12:44 EST | News | La Jolla Pharma +3.2% as director buys $187,000 worth | N/A | |
| 2020-08-24 16:39 EST | Insider Trade | DAVID A RAMSAY has directly acquired 1,000 shares and currently holds 47,000 shares. | Buy | |
| 2020-08-24 16:39 EST | Insider Trade | DAVID A RAMSAY has directly acquired 1,000 shares and currently holds 46,000 shares. | Buy | |
| 2020-08-24 16:39 EST | Insider Trade | DAVID A RAMSAY has directly acquired 4,000 shares and currently holds 45,000 shares. | Buy | |
| 2020-08-24 16:39 EST | Insider Trade | DAVID A RAMSAY has directly acquired 5,000 shares and currently holds 40,000 shares. | Buy | |
| 2020-08-24 16:39 EST | Insider Trade | DAVID A RAMSAY has directly acquired 1,000 shares and currently holds 41,000 shares. | Buy | |
| 2020-08-24 16:39 EST | Insider Trade | DAVID A RAMSAY has directly acquired 2,000 shares and currently holds 35,000 shares. | Buy | |
| 2020-08-24 16:39 EST | Insider Trade | DAVID A RAMSAY has directly acquired 2,000 shares and currently holds 33,000 shares. | Buy | |
| 2020-08-24 16:39 EST | Insider Trade | DAVID A RAMSAY has directly acquired 2,000 shares and currently holds 30,000 shares. | Buy | |
| 2020-08-24 16:39 EST | Insider Trade | DAVID A RAMSAY has directly acquired 1,000 shares and currently holds 31,000 shares. | Buy | |
| 2020-08-24 16:39 EST | Insider Trade | DAVID A RAMSAY has directly acquired 1,000 shares and currently holds 28,000 shares. | Buy | |
| 2020-08-24 16:39 EST | Insider Trade | DAVID A RAMSAY has directly acquired 1,000 shares and currently holds 27,000 shares. | Buy | |
About La Jolla Pharmaceutical Company (LJPC):
La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; TP-271, an IV and oral formulation of a fully synthetic fluorocycline for the treatment of respiratory disease caused by bacterial biothreat and antibiotic-resistant public health pathogens, as well as bacterial pathogens associated with community-acquired bacterial pneumonia; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. The company was incorporated in 1989 and is headquartered in San Diego, California.
General
- Name La Jolla Pharmaceutical Company
- Symbol LJPC
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 59
- Last Split Factor1:50
- Last Split Date2014-01-14
- Fiscal Year EndDecember
- IPO Date1994-06-03
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://lajollapharmaceutical.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 3.93
- Enterprise Value Revenue 3.44
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $0.49
- Next Year EPS Estimate $0.29
- Next Quarter EPS Estimate $0.42
- Profit Margin -118%
- Operating Margin -77%
- Return on Assets -16%
- Revenue 33.42 million
- Earnings Per Share -$5.92
- Revenue Per Share $1.22
- Gross Profit 28.06 million
- Quarterly Earnings Growth 51%
View More
Highlights
- Market Capitalization 140.71 million
- EBITDA -140292992
- PEG Ratio -0.53
- Analyst Target Price $9.33
- Book Value Per Share -$0.61
View More
Share Statistics
- Shares Outstanding 27.43 million
- Shares Float 12.79 million
- % Held by Insiders 146%
- % Held by Institutions 88%
- Shares Short 2.57 million
- Shares Short Prior Month 2.4 million
- Short Ratio 5.32
- Short % of Float 14%
- Short % of Shares Outstanding 9%
View More
Technicals
- Beta 2.57
- 52 Week High $8.1
- 52 Week Low $3.36
- 50 Day Moving Average 6
- 200 Day Moving Average 4.78
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
La Jolla Pharmaceutical Company (LJPC) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
La Jolla Pharmaceutical Company (LJPC) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-08 | $10.95 million | -$0.12 | -$0.34 | 64.71% |
| 2020-09-30 | 2020-11-09 | $N/A | -$0.43 | -$0.62 | 30.65% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.57 | -$0.50 | -14% |
| 2020-03-31 | 2020-05-04 | $N/A | -$0.32 | -$0.77 | 58.62% |
| 2019-12-31 | 2020-03-02 | $7.25 million | -$0.93 | -$0.98 | 5.42% |
| 2019-09-30 | 2019-11-12 | $5.71 million | -$1.08 | -$1.06 | -2.13% |
| 2019-06-30 | 2019-08-01 | $5.7 million | -$1.12 | -$1.10 | -2.12% |
| 2019-03-31 | 2019-05-06 | $4.4 million | -$1.17 | -$1.45 | 19.31% |
| 2018-12-31 | 2019-03-04 | $4.18 million | -$1.73 | -$1.66 | -4.42% |
| 2018-09-30 | 2018-10-24 | $3.47 million | -$1.93 | -$2.01 | 3.97% |
| 2018-06-30 | 2018-08-08 | $1.59 million | -$2.02 | -$1.90 | -6.32% |
| 2018-03-31 | 2018-05-10 | $809000 | -$2.22 | -$1.54 | -43.88% |
| 2017-12-31 | 2018-02-22 | $N/A | -$1.74 | -$1.26 | -37.75% |
| 2017-09-30 | 2017-10-26 | $N/A | -$1.19 | -$1.26 | 5.35% |
| 2017-06-30 | 2017-07-27 | $N/A | -$1.21 | -$1.13 | -7.08% |
| 2017-03-31 | 2017-04-27 | $N/A | -$1.26 | -$1.32 | 4.55% |
| 2016-12-31 | 2017-02-23 | $85000 | -$1.44 | -$1.29 | -11.91% |
| 2016-09-30 | 2016-11-03 | $44000 | -$1.23 | -$0.97 | -26.48% |
| 2016-06-30 | 2016-08-08 | $253000 | -$0.90 | -$0.99 | 8.79% |
| 2016-03-31 | 2016-05-06 | $234000 | -$0.96 | -$0.75 | -28.86% |
| 2015-12-31 | 2016-02-25 | $410000 | -$0.69 | -$0.72 | 4.17% |
| 2015-09-30 | 2015-11-06 | $647000 | -$0.70 | -$0.71 | 1.41% |
| 2015-06-30 | 2015-08-07 | $N/A | -$0.70 | -$0.60 | -16.67% |
| 2015-03-31 | 2015-04-29 | $N/A | -$0.59 | -$0.50 | -18% |
| 2014-12-31 | 2015-03-16 | $N/A | -$0.45 | -$0.37 | -21.62% |
| 2014-09-30 | 2014-11-12 | $N/A | -$0.37 | -$0.31 | -19.35% |
| 2014-06-30 | 2014-08-14 | $N/A | -$0.63 | -$0.69 | 8.7% |
| 2014-03-31 | 2014-04-30 | $N/A | -$0.93 | -$0.94 | 1.06% |
| 2013-12-31 | 2014-03-31 | $N/A | -$72.74 | -$0.23 | -31526.09% |
| 2013-09-30 | 2013-11-11 | $N/A | -$5.45 | ||
| 2013-06-30 | 2013-07-22 | $N/A | -$6.77 | ||
| 2013-03-31 | 2013-05-14 | $N/A | -$12.26 | ||
| 2012-09-30 | 2012-11-02 | $N/A | -$9.16 | ||
| 2012-06-30 | 2012-08-17 | $N/A | -$33.50 | ||
| 2012-03-31 | 2012-05-21 | $N/A | $0.05 | ||
| 2011-12-31 | 2012-03-01 | $N/A | -$1,831.57 | ||
| 2011-09-30 | 2011-10-28 | $N/A | $13.85 | ||
| 2011-06-30 | 2011-08-19 | $N/A | $42.33 | ||
| 2011-03-31 | 2011-05-23 | $N/A | -$34,366.42 | ||
| 2010-12-31 | 2011-03-03 | $N/A | $9,009.75 | ||
| 2010-09-30 | 2010-10-29 | $N/A | -$2,476.24 | ||
| 2010-06-30 | 2010-08-20 | $N/A | -$20,671.65 | ||
| 2010-03-31 | 2010-05-22 | $N/A | -$13,442.78 | ||
| 2009-12-31 | 2010-03-11 | $8.13 million | -$12,956.76 | ||
| 2009-09-30 | 2009-10-30 | $N/A | -$5,310.17 | ||
| 2009-06-30 | 2009-08-18 | $-8125000 | -$15,542.50 | ||
| 2009-03-31 | 2009-04-30 | $8.13 million | -$37,886.48 | ||
| 2008-12-31 | 2009-02-26 | $N/A | -$150,000.00 | ||
| 2008-09-30 | 2008-10-31 | $N/A | -$155,000.00 | -$145,000.00 | -6.9% |
| 2008-06-30 | 2008-08-04 | $N/A | -$155,000.00 | -$160,000.00 | 3.13% |
| 2008-03-31 | 2008-05-01 | $N/A | -$170,000.00 | -$185,000.00 | 8.11% |
| 2007-12-31 | 2008-02-28 | $N/A | -$180,000.00 | -$185,000.00 | 2.7% |
| 2007-09-30 | 2007-11-01 | $N/A | -$170,000.00 | -$172,500.00 | 1.45% |
| 2007-06-30 | 2007-08-02 | $N/A | -$170,000.00 | -$154,000.00 | -10.39% |
| 2007-03-31 | 2007-05-03 | $N/A | -$180,000.00 | -$145,000.00 | -24.14% |
| 2006-12-31 | 2007-03-01 | $N/A | -$165,000.00 | -$140,000.00 | -17.86% |
| 2006-09-30 | 2006-11-02 | $N/A | -$130,000.00 | -$140,000.00 | 7.14% |
| 2006-06-30 | 2006-08-03 | $N/A | -$145,000.00 | -$140,000.00 | -3.57% |
| 2006-03-31 | 2006-05-04 | $N/A | -$165,000.00 | -$245,000.00 | 32.65% |
| 2005-12-31 | 2006-03-02 | $N/A | -$165,262.12 | ||
| 2005-09-30 | 2005-11-03 | $N/A | -$200,000.00 | -$200,000.00 | 0% |
| 2005-06-30 | 2005-08-04 | $N/A | -$211,555.38 | ||
| 2005-03-31 | 2005-05-05 | $N/A | -$325,000.00 | -$375,000.00 | 13.33% |
| 2004-12-31 | 2005-03-03 | $N/A | -$450,000.00 | -$408,333.31 | -10.2% |
| 2004-09-30 | 2004-11-04 | $N/A | -$525,000.00 | -$625,000.00 | 16% |
| 2004-06-30 | 2004-08-05 | $N/A | -$350,000.00 | -$375,000.00 | 6.67% |
| 2004-03-31 | 2004-05-06 | $N/A | -$375,000.00 | -$366,666.69 | -2.27% |
| 2003-12-31 | 2004-03-02 | $N/A | -$425,000.00 | -$343,750.00 | -23.64% |
| 2003-09-30 | 2003-11-06 | $N/A | -$375,000.00 | -$515,000.00 | 27.18% |
| 2003-06-30 | 2003-08-04 | $N/A | -$575,000.00 | -$758,333.31 | 24.18% |
| 2003-03-31 | 2003-05-12 | $N/A | -$800,000.00 | -$700,000.00 | -14.29% |
| 2002-12-31 | 2003-03-04 | $N/A | -$775,000.00 | -$765,000.00 | -1.31% |
| 2002-09-30 | 2002-11-04 | $N/A | -$625,000.00 | -$775,000.00 | 19.35% |
| 2002-06-30 | 2002-08-06 | $N/A | -$675,000.00 | -$550,000.00 | -22.73% |
| 2002-03-31 | 2002-05-07 | $N/A | -$495,070.65 | ||
| 2001-12-31 | 2002-02-26 | $N/A | -$475,000.00 | -$500,000.00 | 5% |
| 2001-09-30 | 2001-09-30 | $N/A | -$379,428.80 | ||
| 2001-06-30 | 2001-06-30 | $N/A | -$434,281.65 | ||
| 2001-03-31 | 2001-03-31 | $N/A | -$500,856.56 | ||
| 2000-12-31 | 2000-12-31 | $N/A | -$354,464.76 | ||
| 2000-09-30 | 2000-09-30 | $N/A | -$376,466.81 | ||
| 2000-06-30 | 2000-06-30 | $N/A | -$306,749.72 | ||
| 2000-03-31 | 2000-03-31 | $N/A | -$323,272.96 | ||
| 1999-09-30 | 1999-09-30 | -$262,524.80 | |||
| 1999-06-30 | 1999-06-30 | -$306,548.66 | |||
| 1999-03-31 | 1999-03-31 | -$260,455.52 | |||
| 1998-09-30 | 1998-11-05 | -$250,000.00 | -$75,000.00 | -233.33% | |
| 1998-06-30 | 1998-08-05 | -$300,000.00 | -$300,000.00 | 0% | |
| 1998-03-31 | 1998-05-07 | -$250,000.00 | -$375,000.00 | 33.33% | |
| 1997-09-30 | 1997-11-06 | -$225,000.00 | -$325,000.00 | 30.77% | |
| 1997-06-30 | 1997-07-31 | -$225,000.00 | -$250,000.00 | 10% | |
| 1997-03-31 | 1997-05-08 | -$175,000.00 | -$375,000.00 | 53.33% | |
| 1996-12-31 | 1997-02-13 | -$100,000.00 | -$562,500.00 | 82.22% | |
| 1996-09-30 | 1996-11-22 | -$475,000.00 | -$562,500.00 | 15.56% | |
| 1996-06-30 | 1996-08-14 | -$525,000.00 | -$575,000.00 | 8.7% | |
| 1996-03-31 | 1996-05-16 | -$525,000.00 | -$337,500.00 | -55.56% | |
| 1995-12-31 | 1996-02-21 | -$575,000.00 | -$987,500.00 | 41.77% | |
| 1995-09-30 | 1995-11-02 | -$75,000.00 | -$25,000.00 | -200% |
La Jolla Pharmaceutical Company (LJPC) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
La Jolla Pharmaceutical Company (LJPC) Chart:
La Jolla Pharmaceutical Company (LJPC) News:
Below you will find a list of latest news for La Jolla Pharmaceutical Company (LJPC) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
La Jolla Pharmaceutical Company (LJPC) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest LJPC Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:47 PM EST | 10 | $3.52 |
| Jun 13, 2022 7:49 PM EST | 5 | $3.52 |
| Jun 13, 2022 7:55 PM EST | 2 | $3.5 |
| Jun 13, 2022 7:59 PM EST | 5 | $3.515 |
| Jun 13, 2022 7:59 PM EST | 2 | $3.5 |
La Jolla Pharmaceutical Company (LJPC) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000116/0000920465-20-000116-index.htm |
| 2019-08-26 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/920465/000000000019012862/0000000000-19-012862-index.htm |
| 2019-09-26 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/920465/000000000019014009/0000000000-19-014009-index.htm |
| 2019-10-16 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/920465/000000000019014597/0000000000-19-014597-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/920465/000005341720000040/0000053417-20-000040-index.htm |
| 2019-12-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/920465/000031506619001802/0000315066-19-001802-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/920465/000031506620001073/0000315066-20-001073-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/920465/000083423720005996/0000834237-20-005996-index.htm |
| 2019-04-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/920465/000089109219004449/0000891092-19-004449-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/920465/000091957420001135/0000919574-20-001135-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000047/0000920465-19-000047-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000048/0000920465-19-000048-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000049/0000920465-19-000049-index.htm |
| 2019-03-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000051/0000920465-19-000051-index.htm |
| 2019-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000052/0000920465-19-000052-index.htm |
| 2019-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000053/0000920465-19-000053-index.htm |
| 2019-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000054/0000920465-19-000054-index.htm |
| 2019-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000055/0000920465-19-000055-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000056/0000920465-19-000056-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000057/0000920465-19-000057-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000058/0000920465-19-000058-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000059/0000920465-19-000059-index.htm |
| 2019-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000060/0000920465-19-000060-index.htm |
| 2019-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000061/0000920465-19-000061-index.htm |
| 2019-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000062/0000920465-19-000062-index.htm |
| 2019-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000063/0000920465-19-000063-index.htm |
| 2019-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000064/0000920465-19-000064-index.htm |
| 2019-04-30 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/920465/000092046519000067/0000920465-19-000067-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000068/0000920465-19-000068-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000069/0000920465-19-000069-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000070/0000920465-19-000070-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000071/0000920465-19-000071-index.htm |
| 2019-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/920465/000092046519000077/0000920465-19-000077-index.htm |
| 2019-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046519000078/0000920465-19-000078-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000079/0000920465-19-000079-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000080/0000920465-19-000080-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000081/0000920465-19-000081-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000082/0000920465-19-000082-index.htm |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000083/0000920465-19-000083-index.htm |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000084/0000920465-19-000084-index.htm |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000085/0000920465-19-000085-index.htm |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000086/0000920465-19-000086-index.htm |
| 2019-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000087/0000920465-19-000087-index.htm |
| 2019-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000088/0000920465-19-000088-index.htm |
| 2019-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000089/0000920465-19-000089-index.htm |
| 2019-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000090/0000920465-19-000090-index.htm |
| 2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000091/0000920465-19-000091-index.htm |
| 2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000092/0000920465-19-000092-index.htm |
| 2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000093/0000920465-19-000093-index.htm |
| 2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000094/0000920465-19-000094-index.htm |
| 2019-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000095/0000920465-19-000095-index.htm |
| 2019-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000096/0000920465-19-000096-index.htm |
| 2019-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000097/0000920465-19-000097-index.htm |
| 2019-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000098/0000920465-19-000098-index.htm |
| 2019-08-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/920465/000092046519000101/0000920465-19-000101-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000102/0000920465-19-000102-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000103/0000920465-19-000103-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000104/0000920465-19-000104-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000105/0000920465-19-000105-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046519000107/0000920465-19-000107-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000109/0000920465-19-000109-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000110/0000920465-19-000110-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000111/0000920465-19-000111-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000112/0000920465-19-000112-index.htm |
| 2019-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000118/0000920465-19-000118-index.htm |
| 2019-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000119/0000920465-19-000119-index.htm |
| 2019-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000120/0000920465-19-000120-index.htm |
| 2019-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000121/0000920465-19-000121-index.htm |
| 2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000126/0000920465-19-000126-index.htm |
| 2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000127/0000920465-19-000127-index.htm |
| 2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000128/0000920465-19-000128-index.htm |
| 2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000129/0000920465-19-000129-index.htm |
| 2019-09-18 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/920465/000092046519000131/0000920465-19-000131-index.htm |
| 2019-09-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/920465/000092046519000133/0000920465-19-000133-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000134/0000920465-19-000134-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000135/0000920465-19-000135-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000136/0000920465-19-000136-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000137/0000920465-19-000137-index.htm |
| 2019-10-09 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/920465/000092046519000139/0000920465-19-000139-index.htm |
| 2019-10-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046519000141/0000920465-19-000141-index.htm |
| 2019-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000142/0000920465-19-000142-index.htm |
| 2019-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000143/0000920465-19-000143-index.htm |
| 2019-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000144/0000920465-19-000144-index.htm |
| 2019-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000145/0000920465-19-000145-index.htm |
| 2019-10-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000147/0000920465-19-000147-index.htm |
| 2019-10-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000149/0000920465-19-000149-index.htm |
| 2019-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000150/0000920465-19-000150-index.htm |
| 2019-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000151/0000920465-19-000151-index.htm |
| 2019-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000152/0000920465-19-000152-index.htm |
| 2019-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000153/0000920465-19-000153-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/920465/000092046519000156/0000920465-19-000156-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000161/0000920465-19-000161-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000162/0000920465-19-000162-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000163/0000920465-19-000163-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000164/0000920465-19-000164-index.htm |
| 2019-11-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046519000166/0000920465-19-000166-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000167/0000920465-19-000167-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000168/0000920465-19-000168-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000169/0000920465-19-000169-index.htm |
| 2019-12-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046519000172/0000920465-19-000172-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000173/0000920465-19-000173-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000174/0000920465-19-000174-index.htm |
| 2019-12-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046519000176/0000920465-19-000176-index.htm |
| 2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000181/0000920465-19-000181-index.htm |
| 2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000182/0000920465-19-000182-index.htm |
| 2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000183/0000920465-19-000183-index.htm |
| 2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046519000184/0000920465-19-000184-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000003/0000920465-20-000003-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000004/0000920465-20-000004-index.htm |
| 2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046520000006/0000920465-20-000006-index.htm |
| 2020-01-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000012/0000920465-20-000012-index.htm |
| 2020-01-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000013/0000920465-20-000013-index.htm |
| 2020-01-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000014/0000920465-20-000014-index.htm |
| 2020-01-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000015/0000920465-20-000015-index.htm |
| 2020-01-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000016/0000920465-20-000016-index.htm |
| 2020-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000018/0000920465-20-000018-index.htm |
| 2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000022/0000920465-20-000022-index.htm |
| 2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000023/0000920465-20-000023-index.htm |
| 2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000024/0000920465-20-000024-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000025/0000920465-20-000025-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000026/0000920465-20-000026-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000027/0000920465-20-000027-index.htm |
| 2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000032/0000920465-20-000032-index.htm |
| 2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000033/0000920465-20-000033-index.htm |
| 2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000034/0000920465-20-000034-index.htm |
| 2020-03-02 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/920465/000092046520000036/0000920465-20-000036-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000037/0000920465-20-000037-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000038/0000920465-20-000038-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000039/0000920465-20-000039-index.htm |
| 2020-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046520000041/0000920465-20-000041-index.htm |
| 2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000042/0000920465-20-000042-index.htm |
| 2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000043/0000920465-20-000043-index.htm |
| 2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000044/0000920465-20-000044-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000045/0000920465-20-000045-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000046/0000920465-20-000046-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000047/0000920465-20-000047-index.htm |
| 2020-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000048/0000920465-20-000048-index.htm |
| 2020-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000049/0000920465-20-000049-index.htm |
| 2020-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000050/0000920465-20-000050-index.htm |
| 2020-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000051/0000920465-20-000051-index.htm |
| 2020-04-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046520000053/0000920465-20-000053-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/920465/000092046520000055/0000920465-20-000055-index.htm |
| 2020-05-04 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/920465/000092046520000057/0000920465-20-000057-index.htm |
| 2020-05-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/920465/000092046520000059/0000920465-20-000059-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000063/0000920465-20-000063-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000064/0000920465-20-000064-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000065/0000920465-20-000065-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046520000067/0000920465-20-000067-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046520000070/0000920465-20-000070-index.htm |
| 2020-05-12 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/920465/000092046520000071/0000920465-20-000071-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000074/0000920465-20-000074-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000075/0000920465-20-000075-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000076/0000920465-20-000076-index.htm |
| 2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046520000078/0000920465-20-000078-index.htm |
| 2020-06-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046520000080/0000920465-20-000080-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000081/0000920465-20-000081-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000082/0000920465-20-000082-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000083/0000920465-20-000083-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000086/0000920465-20-000086-index.htm |
| 2020-06-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000087/0000920465-20-000087-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000088/0000920465-20-000088-index.htm |
| 2020-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046520000097/0000920465-20-000097-index.htm |
| 2020-06-22 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/920465/000092046520000098/0000920465-20-000098-index.htm |
| 2020-06-22 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000102/0000920465-20-000102-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000103/0000920465-20-000103-index.htm |
| 2020-06-22 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/920465/000092046520000104/0000920465-20-000104-index.htm |
| 2020-06-26 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/920465/000092046520000109/0000920465-20-000109-index.htm |
| 2020-06-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046520000113/0000920465-20-000113-index.htm |
| 2020-07-01 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/920465/000092046520000115/0000920465-20-000115-index.htm |
| 2020-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000116/0000920465-20-000116-index.htm |
| 2020-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000117/0000920465-20-000117-index.htm |
| 2020-07-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046520000119/0000920465-20-000119-index.htm |
| 2020-07-29 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/920465/000092046520000122/0000920465-20-000122-index.htm |
| 2020-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000123/0000920465-20-000123-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000124/0000920465-20-000124-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/920465/000092046520000127/0000920465-20-000127-index.htm |
| 2020-08-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000130/0000920465-20-000130-index.htm |
| 2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046520000133/0000920465-20-000133-index.htm |
| 2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000135/0000920465-20-000135-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000139/0000920465-20-000139-index.htm |
| 2020-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000141/0000920465-20-000141-index.htm |
| 2020-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046520000143/0000920465-20-000143-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000145/0000920465-20-000145-index.htm |
| 2020-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000092046520000147/0000920465-20-000147-index.htm |
| 2020-10-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000151/0000920465-20-000151-index.htm |
| 2020-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000092046520000156/0000920465-20-000156-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/920465/000110465920019737/0001104659-20-019737-index.htm |
| 2020-06-29 | SC TO-T | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/920465/000114036120014992/0001140361-20-014992-index.htm |
| 2020-07-29 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/920465/000114036120016895/0001140361-20-016895-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/920465/000119312520038106/0001193125-20-038106-index.htm |
| 2020-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000119312520177095/0001193125-20-177095-index.htm |
| 2020-06-24 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/920465/000119312520177096/0001193125-20-177096-index.htm |
| 2020-10-13 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/920465/000119312520268550/0001193125-20-268550-index.htm |
| 2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000120919119061769/0001209191-19-061769-index.htm |
| 2020-01-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000120919120003214/0001209191-20-003214-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000120919120006077/0001209191-20-006077-index.htm |
| 2020-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000120919120034535/0001209191-20-034535-index.htm |
| 2020-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000120919120046812/0001209191-20-046812-index.htm |
| 2020-09-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/920465/000120919120049871/0001209191-20-049871-index.htm |
| 2020-01-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/920465/000121465920000311/0001214659-20-000311-index.htm |
| 2020-06-05 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/920465/000121465920005418/0001214659-20-005418-index.htm |
| 2020-08-18 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/920465/000121465920007288/0001214659-20-007288-index.htm |
| 2020-09-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/920465/000121465920007778/0001214659-20-007778-index.htm |
| 2019-06-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/920465/000149315219009179/0001493152-19-009179-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/920465/000149315220002402/0001493152-20-002402-index.htm |
| 2020-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000156459020049340/0001564590-20-049340-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/920465/000156459020051438/0001564590-20-051438-index.htm |
La Jolla Pharmaceutical Company (LJPC) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of La Jolla Pharmaceutical Company (LJPC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 146%Institutional Ownership: 8800%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-06-15 | Lakhmir S Chawla | Chief Medical Officer | Buy | 435.00 | 4.51 | 1,961.85 | 10,377.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000088/0000920465-20-000088-index.htm |
| 2020-06-19 | JOLLA PHARMACEUTICAL CO LA | 10% Share Holder | Buy | 234,698.00 | 2.62 | 613,993.44 | 1,085,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000103/0000920465-20-000103-index.htm |
| 2020-06-30 | Lakhmir S Chawla | Chief Medical Officer | Buy | 543.00 | 3.62 | 1,965.66 | 10,920.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000116/0000920465-20-000116-index.htm |
| 2019-05-31 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 347.00 | 4.58 | 1,589.26 | 1,126.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000084/0000920465-19-000084-index.htm |
| 2020-07-15 | Lakhmir S Chawla | Chief Medical Officer | Buy | 521.00 | 3.77 | 1,964.17 | 11,441.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000117/0000920465-20-000117-index.htm |
| 2019-02-28 | DENNIS MULROY | Chief Financial Officer | Buy | 65.00 | 4.85 | 315.25 | 1,165.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000047/0000920465-19-000047-index.htm |
| 2020-08-20 | DAVID A RAMSAY | Director | Buy | 2,530.00 | 4.18 | 10,575.40 | 12,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2020-07-31 | Lakhmir S Chawla | Chief Medical Officer | Buy | 581.00 | 3.38 | 1,963.78 | 12,022.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000124/0000920465-20-000124-index.htm |
| 2019-03-15 | DENNIS MULROY | Chief Financial Officer | Buy | 49.00 | 6.49 | 318.01 | 1,214.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000052/0000920465-19-000052-index.htm |
| 2020-08-14 | Lakhmir S Chawla | Chief Medical Officer | Buy | 589.00 | 3.34 | 1,967.26 | 12,611.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000135/0000920465-20-000135-index.htm |
| 2019-02-28 | GEORGE F TIDMARSH | President, CEO & Secretary | Buy | 261.00 | 4.85 | 1,265.85 | 1,263,604.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000049/0000920465-19-000049-index.htm |
| 2019-03-15 | GEORGE F TIDMARSH | President, CEO & Secretary | Buy | 195.00 | 6.49 | 1,265.55 | 1,263,799.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000055/0000920465-19-000055-index.htm |
| 2019-03-29 | GEORGE F TIDMARSH | President, CEO & Secretary | Buy | 94.00 | 5.47 | 514.18 | 1,263,893.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000057/0000920465-19-000057-index.htm |
| 2019-04-15 | GEORGE F TIDMARSH | President, CEO & Secretary | Buy | 2.00 | 6.09 | 12.18 | 1,263,895.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000062/0000920465-19-000062-index.htm |
| 2019-03-29 | DENNIS MULROY | Chief Financial Officer | Buy | 59.00 | 5.47 | 322.73 | 1,273.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000058/0000920465-19-000058-index.htm |
| 2020-08-31 | Lakhmir S Chawla | Chief Medical Officer | Buy | 550.00 | 3.57 | 1,963.50 | 13,161.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000139/0000920465-20-000139-index.htm |
| 2019-06-14 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 193.00 | 8.25 | 1,592.25 | 1,319.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000090/0000920465-19-000090-index.htm |
| 2020-09-15 | Lakhmir S Chawla | Chief Medical Officer | Buy | 286.00 | 3.85 | 1,101.10 | 13,447.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000145/0000920465-20-000145-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 2,000.00 | 3.84 | 7,680.00 | 14,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-06-28 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 202.00 | 7.86 | 1,587.72 | 1,521.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000092/0000920465-19-000092-index.htm |
| 2019-04-15 | DENNIS MULROY | Chief Financial Officer | Buy | 261.00 | 6.09 | 1,589.49 | 1,534.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000061/0000920465-19-000061-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 2,000.00 | 3.85 | 7,700.00 | 16,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2020-10-15 | Michael S Hearne | Chief Financial Officer | Buy | 169.00 | 3.32 | 561.08 | 169.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000151/0000920465-20-000151-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 1,000.00 | 3.86 | 3,860.00 | 17,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-07-15 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 203.00 | 7.85 | 1,593.55 | 1,724.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000097/0000920465-19-000097-index.htm |
| 2019-04-30 | DENNIS MULROY | Chief Financial Officer | Buy | 233.00 | 6.84 | 1,593.72 | 1,767.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000071/0000920465-19-000071-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 1,000.00 | 3.87 | 3,870.00 | 18,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 1,000.00 | 3.88 | 3,880.00 | 19,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-07-31 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 224.00 | 7.11 | 1,592.64 | 1,948.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000103/0000920465-19-000103-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 1,000.00 | 3.90 | 3,900.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-05-15 | DENNIS MULROY | Chief Financial Officer | Buy | 285.00 | 5.58 | 1,590.30 | 2,052.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000079/0000920465-19-000079-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 1,000.00 | 3.92 | 3,920.00 | 21,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-08-15 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 198.00 | 8.02 | 1,587.96 | 2,146.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000109/0000920465-19-000109-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 1,000.00 | 3.93 | 3,930.00 | 22,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-08-30 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 196.00 | 8.13 | 1,593.48 | 2,342.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000120/0000920465-19-000120-index.htm |
| 2019-05-31 | DENNIS MULROY | Chief Financial Officer | Buy | 347.00 | 4.58 | 1,589.26 | 2,399.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000083/0000920465-19-000083-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 2,000.00 | 3.94 | 7,888.00 | 24,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 1,000.00 | 3.95 | 3,950.00 | 25,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-09-13 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 171.00 | 9.28 | 1,586.88 | 2,513.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000127/0000920465-19-000127-index.htm |
| 2019-06-14 | DENNIS MULROY | Chief Financial Officer | Buy | 193.00 | 8.25 | 1,592.25 | 2,592.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000089/0000920465-19-000089-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 1,000.00 | 3.97 | 3,970.00 | 26,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-04-15 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 261.00 | 6.09 | 1,589.49 | 261.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000063/0000920465-19-000063-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 1,000.00 | 3.98 | 3,980.00 | 27,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-09-30 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 213.00 | 7.48 | 1,593.24 | 2,726.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000134/0000920465-19-000134-index.htm |
| 2019-06-28 | DENNIS MULROY | Chief Financial Officer | Buy | 202.00 | 7.86 | 1,587.72 | 2,794.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000094/0000920465-19-000094-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 1,000.00 | 4.00 | 4,000.00 | 28,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-10-15 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 224.00 | 7.12 | 1,594.88 | 2,950.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000145/0000920465-19-000145-index.htm |
| 2019-07-15 | DENNIS MULROY | Chief Financial Officer | Buy | 203.00 | 7.85 | 1,593.55 | 2,997.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000098/0000920465-19-000098-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 2,000.00 | 4.01 | 8,020.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 1,000.00 | 4.02 | 4,020.00 | 31,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-10-31 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 267.00 | 5.96 | 1,591.32 | 3,217.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000152/0000920465-19-000152-index.htm |
| 2019-07-31 | DENNIS MULROY | Chief Financial Officer | Buy | 224.00 | 7.11 | 1,592.64 | 3,221.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000105/0000920465-19-000105-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 2,000.00 | 4.03 | 8,060.00 | 33,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-08-15 | DENNIS MULROY | Chief Financial Officer | Buy | 198.00 | 8.02 | 1,587.96 | 3,419.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000110/0000920465-19-000110-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 2,000.00 | 4.04 | 8,080.00 | 35,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-11-15 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 311.00 | 5.12 | 1,592.32 | 3,528.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000163/0000920465-19-000163-index.htm |
| 2019-11-29 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 17.00 | 2.33 | 39.61 | 3,545.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000167/0000920465-19-000167-index.htm |
| 2019-08-30 | DENNIS MULROY | Chief Financial Officer | Buy | 196.00 | 8.13 | 1,593.48 | 3,615.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000121/0000920465-19-000121-index.htm |
| 2020-10-30 | Michael S Hearne | Chief Financial Officer | Buy | 196.00 | 2.89 | 566.44 | 365.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000156/0000920465-20-000156-index.htm |
| 2019-09-13 | DENNIS MULROY | Chief Financial Officer | Buy | 171.00 | 9.28 | 1,586.88 | 3,786.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000128/0000920465-19-000128-index.htm |
| 2019-09-30 | DENNIS MULROY | Chief Financial Officer | Buy | 213.00 | 7.48 | 1,593.24 | 3,999.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000136/0000920465-19-000136-index.htm |
| 2020-08-21 | DAVID A RAMSAY | Director | Buy | 5,000.00 | 4.08 | 20,400.00 | 40,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2020-08-24 | DAVID A RAMSAY | Director | Buy | 1,000.00 | 3.82 | 3,818.50 | 41,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-10-15 | DENNIS MULROY | Chief Financial Officer | Buy | 224.00 | 7.12 | 1,594.88 | 4,223.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000143/0000920465-19-000143-index.htm |
| 2019-10-31 | DENNIS MULROY | Chief Financial Officer | Buy | 267.00 | 5.96 | 1,591.32 | 4,490.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000150/0000920465-19-000150-index.htm |
| 2020-08-24 | DAVID A RAMSAY | Director | Buy | 4,000.00 | 3.75 | 15,000.00 | 45,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-11-15 | DENNIS MULROY | Chief Financial Officer | Buy | 62.00 | 5.12 | 317.44 | 4,552.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000162/0000920465-19-000162-index.htm |
| 2020-08-24 | DAVID A RAMSAY | Director | Buy | 1,000.00 | 3.74 | 3,740.00 | 46,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-11-29 | DENNIS MULROY | Chief Financial Officer | Buy | 138.00 | 2.33 | 321.54 | 4,690.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000168/0000920465-19-000168-index.htm |
| 2020-08-24 | DAVID A RAMSAY | Director | Buy | 1,000.00 | 3.73 | 3,730.00 | 47,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2020-09-08 | DAVID A RAMSAY | Director | Buy | 1,000.00 | 3.83 | 3,830.00 | 48,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000141/0000920465-20-000141-index.htm |
| 2019-12-13 | DENNIS MULROY | Chief Financial Officer | Buy | 112.00 | 2.85 | 319.20 | 4,802.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000174/0000920465-19-000174-index.htm |
| 2019-12-31 | DENNIS MULROY | Chief Financial Officer | Buy | 16.00 | 3.34 | 53.44 | 4,818.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000003/0000920465-20-000003-index.htm |
| 2020-07-28 | JOLLA PHARMACEUTICAL CO LA | 10% Share Holder | Buy | 3,737,360.00 | 2.00 | 7,474,720.00 | 4,822,360.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000123/0000920465-20-000123-index.htm |
| 2020-04-15 | DENNIS MULROY | Chief Financial Officer | Buy | 58.00 | 5.61 | 325.38 | 4,876.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000051/0000920465-20-000051-index.htm |
| 2020-04-30 | DENNIS MULROY | Chief Financial Officer | Buy | 53.00 | 6.17 | 327.01 | 4,929.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000063/0000920465-20-000063-index.htm |
| 2019-04-30 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 233.00 | 6.84 | 1,593.72 | 494.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000068/0000920465-19-000068-index.htm |
| 2020-05-15 | DENNIS MULROY | Chief Financial Officer | Buy | 56.00 | 5.86 | 328.16 | 4,985.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000076/0000920465-20-000076-index.htm |
| 2020-05-29 | DENNIS MULROY | Chief Financial Officer | Buy | 82.00 | 4.01 | 328.82 | 5,067.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000083/0000920465-20-000083-index.htm |
| 2019-03-15 | Lakhmir S Chawla | Chief Medical Officer | Buy | 29.00 | 6.49 | 188.21 | 5,401.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000053/0000920465-19-000053-index.htm |
| 2019-03-29 | Lakhmir S Chawla | Chief Medical Officer | Buy | 35.00 | 5.47 | 191.45 | 5,436.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000056/0000920465-19-000056-index.htm |
| 2019-04-15 | Lakhmir S Chawla | Chief Medical Officer | Buy | 94.00 | 6.09 | 572.46 | 5,530.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000064/0000920465-19-000064-index.htm |
| 2020-01-09 | KEVIN C TANG | Director | Buy | 599,661.00 | 4.80 | 2,880,231.75 | 5,538,554.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120003214/0001209191-20-003214-index.htm |
| 2019-04-30 | Lakhmir S Chawla | Chief Medical Officer | Buy | 84.00 | 6.84 | 574.56 | 5,614.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000069/0000920465-19-000069-index.htm |
| 2019-05-15 | Lakhmir S Chawla | Chief Medical Officer | Buy | 102.00 | 5.58 | 569.16 | 5,716.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000080/0000920465-19-000080-index.htm |
| 2019-05-31 | Lakhmir S Chawla | Chief Medical Officer | Buy | 126.00 | 4.58 | 577.08 | 5,842.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000086/0000920465-19-000086-index.htm |
| 2019-06-14 | Lakhmir S Chawla | Chief Medical Officer | Buy | 69.00 | 8.25 | 569.25 | 5,911.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000087/0000920465-19-000087-index.htm |
| 2020-01-09 | KEVIN C TANG | Director | Buy | 400,339.00 | 5.27 | 2,111,748.19 | 5,938,893.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120003214/0001209191-20-003214-index.htm |
| 2019-06-28 | Lakhmir S Chawla | Chief Medical Officer | Buy | 73.00 | 7.86 | 573.78 | 5,984.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000091/0000920465-19-000091-index.htm |
| 2020-08-20 | DAVID A RAMSAY | Director | Buy | 6,000.00 | 4.17 | 25,014.60 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2019-07-15 | Lakhmir S Chawla | Chief Medical Officer | Buy | 73.00 | 7.85 | 573.05 | 6,057.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000095/0000920465-19-000095-index.htm |
| 2019-07-31 | Lakhmir S Chawla | Chief Medical Officer | Buy | 80.00 | 7.11 | 568.80 | 6,137.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000104/0000920465-19-000104-index.htm |
| 2019-08-15 | Lakhmir S Chawla | Chief Medical Officer | Buy | 72.00 | 8.02 | 577.44 | 6,209.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000111/0000920465-19-000111-index.htm |
| 2019-08-30 | Lakhmir S Chawla | Chief Medical Officer | Buy | 70.00 | 8.13 | 569.10 | 6,279.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000119/0000920465-19-000119-index.htm |
| 2019-09-13 | Lakhmir S Chawla | Chief Medical Officer | Buy | 62.00 | 9.28 | 575.36 | 6,341.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000126/0000920465-19-000126-index.htm |
| 2019-09-30 | Lakhmir S Chawla | Chief Medical Officer | Buy | 76.00 | 7.48 | 568.48 | 6,417.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000135/0000920465-19-000135-index.htm |
| 2019-10-15 | Lakhmir S Chawla | Chief Medical Officer | Buy | 81.00 | 7.12 | 576.72 | 6,498.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000144/0000920465-19-000144-index.htm |
| 2020-01-14 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 3,000.00 | 8.23 | 24,676.50 | 6,545.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000018/0000920465-20-000018-index.htm |
| 2019-10-31 | Lakhmir S Chawla | Chief Medical Officer | Buy | 96.00 | 5.96 | 572.16 | 6,594.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000151/0000920465-19-000151-index.htm |
| 2020-01-10 | KEVIN C TANG | Director | Buy | 717,804.00 | 5.70 | 4,090,908.56 | 6,656,697.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120003214/0001209191-20-003214-index.htm |
| 2019-11-15 | Lakhmir S Chawla | Chief Medical Officer | Buy | 111.00 | 5.12 | 568.32 | 6,705.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000161/0000920465-19-000161-index.htm |
| 2019-11-29 | Lakhmir S Chawla | Chief Medical Officer | Buy | 247.00 | 2.33 | 575.51 | 6,952.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000169/0000920465-19-000169-index.htm |
| 2019-12-13 | Lakhmir S Chawla | Chief Medical Officer | Buy | 201.00 | 2.85 | 572.85 | 7,153.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000173/0000920465-19-000173-index.htm |
| 2019-12-31 | Lakhmir S Chawla | Chief Medical Officer | Buy | 172.00 | 3.34 | 574.48 | 7,325.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000004/0000920465-20-000004-index.htm |
| 2020-01-15 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 1,188.00 | 6.70 | 7,959.60 | 7,733.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000024/0000920465-20-000024-index.htm |
| 2019-02-28 | James Rolke | Chief Scientific Officer | Buy | 164.00 | 4.85 | 795.40 | 77,592.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000048/0000920465-19-000048-index.htm |
| 2019-03-15 | James Rolke | Chief Scientific Officer | Buy | 122.00 | 6.49 | 791.78 | 77,714.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000054/0000920465-19-000054-index.htm |
| 2019-03-29 | James Rolke | Chief Scientific Officer | Buy | 146.00 | 5.47 | 798.62 | 77,860.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000059/0000920465-19-000059-index.htm |
| 2019-05-15 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 285.00 | 5.58 | 1,590.30 | 779.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000081/0000920465-19-000081-index.htm |
| 2019-04-15 | James Rolke | Chief Scientific Officer | Buy | 131.00 | 6.09 | 797.79 | 77,991.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000060/0000920465-19-000060-index.htm |
| 2019-04-30 | James Rolke | Chief Scientific Officer | Buy | 116.00 | 6.84 | 793.44 | 78,107.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000070/0000920465-19-000070-index.htm |
| 2020-01-15 | Lakhmir S Chawla | Chief Medical Officer | Buy | 498.00 | 6.70 | 3,336.60 | 7,823.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000023/0000920465-20-000023-index.htm |
| 2019-05-15 | James Rolke | Chief Scientific Officer | Buy | 143.00 | 5.58 | 797.94 | 78,250.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000082/0000920465-19-000082-index.htm |
| 2019-05-31 | James Rolke | Chief Scientific Officer | Buy | 174.00 | 4.58 | 796.92 | 78,424.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000085/0000920465-19-000085-index.htm |
| 2019-06-14 | James Rolke | Chief Scientific Officer | Buy | 96.00 | 8.25 | 792.00 | 78,520.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000088/0000920465-19-000088-index.htm |
| 2019-06-28 | James Rolke | Chief Scientific Officer | Buy | 101.00 | 7.86 | 793.86 | 78,621.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000093/0000920465-19-000093-index.htm |
| 2019-07-15 | James Rolke | Chief Scientific Officer | Buy | 102.00 | 7.85 | 800.70 | 78,723.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000096/0000920465-19-000096-index.htm |
| 2019-07-31 | James Rolke | Chief Scientific Officer | Buy | 112.00 | 7.11 | 796.32 | 78,835.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000102/0000920465-19-000102-index.htm |
| 2019-08-15 | James Rolke | Chief Scientific Officer | Buy | 99.00 | 8.02 | 793.98 | 78,934.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000112/0000920465-19-000112-index.htm |
| 2019-08-30 | James Rolke | Chief Scientific Officer | Buy | 98.00 | 8.13 | 796.74 | 79,032.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000118/0000920465-19-000118-index.htm |
| 2020-01-13 | KEVIN C TANG | Director | Buy | 1,253,878.00 | 6.66 | 8,351,579.81 | 7,910,575.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120003214/0001209191-20-003214-index.htm |
| 2019-09-13 | James Rolke | Chief Scientific Officer | Buy | 85.00 | 9.28 | 788.80 | 79,117.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000129/0000920465-19-000129-index.htm |
| 2019-09-30 | James Rolke | Chief Scientific Officer | Buy | 107.00 | 7.48 | 800.36 | 79,224.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000137/0000920465-19-000137-index.htm |
| 2020-01-31 | Lakhmir S Chawla | Chief Medical Officer | Buy | 101.00 | 5.82 | 587.82 | 7,924.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000027/0000920465-20-000027-index.htm |
| 2019-10-15 | James Rolke | Chief Scientific Officer | Buy | 112.00 | 7.12 | 797.44 | 79,336.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000142/0000920465-19-000142-index.htm |
| 2019-10-31 | James Rolke | Chief Scientific Officer | Buy | 133.00 | 5.96 | 792.68 | 79,469.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000153/0000920465-19-000153-index.htm |
| 2019-11-15 | James Rolke | Chief Scientific Officer | Buy | 118.00 | 5.12 | 604.16 | 79,587.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046519000164/0000920465-19-000164-index.htm |
| 2020-01-30 | KEVIN C TANG | Director | Buy | 81,475.00 | 6.72 | 547,430.53 | 7,992,050.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120006077/0001209191-20-006077-index.htm |
| 2020-01-31 | KEVIN C TANG | Director | Buy | 13,292.00 | 6.75 | 89,705.05 | 8,005,342.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120006077/0001209191-20-006077-index.htm |
| 2020-02-14 | Lakhmir S Chawla | Chief Medical Officer | Buy | 83.00 | 7.14 | 592.62 | 8,007.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000033/0000920465-20-000033-index.htm |
| 2020-01-31 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 282.00 | 5.82 | 1,641.24 | 8,015.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000025/0000920465-20-000025-index.htm |
| 2020-01-15 | James Rolke | Chief Scientific Officer | Buy | 692.00 | 6.70 | 4,636.40 | 80,279.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000022/0000920465-20-000022-index.htm |
| 2020-01-31 | James Rolke | Chief Scientific Officer | Buy | 141.00 | 5.82 | 820.62 | 80,420.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000026/0000920465-20-000026-index.htm |
| 2020-02-14 | James Rolke | Chief Scientific Officer | Buy | 115.00 | 7.14 | 821.10 | 80,535.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000032/0000920465-20-000032-index.htm |
| 2020-02-28 | James Rolke | Chief Scientific Officer | Buy | 142.00 | 5.78 | 820.76 | 80,677.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000039/0000920465-20-000039-index.htm |
| 2020-02-03 | KEVIN C TANG | Director | Buy | 75,003.00 | 6.80 | 509,832.89 | 8,080,345.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120006077/0001209191-20-006077-index.htm |
| 2020-03-13 | James Rolke | Chief Scientific Officer | Buy | 241.00 | 3.40 | 819.40 | 80,918.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000044/0000920465-20-000044-index.htm |
| 2020-02-28 | Lakhmir S Chawla | Chief Medical Officer | Buy | 102.00 | 5.78 | 589.56 | 8,109.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000038/0000920465-20-000038-index.htm |
| 2020-03-31 | James Rolke | Chief Scientific Officer | Buy | 229.00 | 3.57 | 817.53 | 81,147.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000045/0000920465-20-000045-index.htm |
| 2020-04-15 | James Rolke | Chief Scientific Officer | Buy | 146.00 | 5.61 | 819.06 | 81,293.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000048/0000920465-20-000048-index.htm |
| 2020-04-30 | James Rolke | Chief Scientific Officer | Buy | 133.00 | 6.17 | 820.61 | 81,426.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000065/0000920465-20-000065-index.htm |
| 2020-05-15 | James Rolke | Chief Scientific Officer | Buy | 140.00 | 5.86 | 820.40 | 81,566.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000074/0000920465-20-000074-index.htm |
| 2020-05-29 | James Rolke | Chief Scientific Officer | Buy | 205.00 | 4.01 | 822.05 | 81,771.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000081/0000920465-20-000081-index.htm |
| 2020-02-14 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 229.00 | 7.14 | 1,635.06 | 8,244.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000034/0000920465-20-000034-index.htm |
| 2020-03-13 | Lakhmir S Chawla | Chief Medical Officer | Buy | 173.00 | 3.40 | 588.20 | 8,282.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000042/0000920465-20-000042-index.htm |
| 2020-06-02 | KEVIN C TANG | Director | Buy | 253,553.00 | 4.88 | 1,237,059.73 | 8,333,898.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120034535/0001209191-20-034535-index.htm |
| 2020-03-31 | Lakhmir S Chawla | Chief Medical Officer | Buy | 165.00 | 3.57 | 589.05 | 8,447.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000047/0000920465-20-000047-index.htm |
| 2020-06-03 | KEVIN C TANG | Director | Buy | 145,764.00 | 4.90 | 714,782.93 | 8,479,662.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120034535/0001209191-20-034535-index.htm |
| 2020-02-28 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 284.00 | 5.78 | 1,641.52 | 8,528.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000037/0000920465-20-000037-index.htm |
| 2020-06-04 | KEVIN C TANG | Director | Buy | 215,812.00 | 4.94 | 1,065,636.49 | 8,695,474.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120034535/0001209191-20-034535-index.htm |
| 2020-08-12 | KEVIN C TANG | Director | Buy | 43,513.00 | 3.47 | 150,820.41 | 8,738,987.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120046812/0001209191-20-046812-index.htm |
| 2020-04-15 | Lakhmir S Chawla | Chief Medical Officer | Buy | 350.00 | 5.61 | 1,963.50 | 8,797.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000049/0000920465-20-000049-index.htm |
| 2020-08-13 | KEVIN C TANG | Director | Buy | 219,465.00 | 3.65 | 800,586.37 | 8,958,452.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120046812/0001209191-20-046812-index.htm |
| 2020-03-13 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 483.00 | 3.40 | 1,642.20 | 9,011.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000043/0000920465-20-000043-index.htm |
| 2020-04-30 | Lakhmir S Chawla | Chief Medical Officer | Buy | 319.00 | 6.17 | 1,968.23 | 9,116.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000064/0000920465-20-000064-index.htm |
| 2020-08-14 | KEVIN C TANG | Director | Buy | 168,669.00 | 3.88 | 653,693.58 | 9,127,121.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120046812/0001209191-20-046812-index.htm |
| 2020-09-04 | KEVIN C TANG | Director | Buy | 67,552.00 | 3.82 | 258,359.38 | 9,194,673.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120049871/0001209191-20-049871-index.htm |
| 2020-09-08 | KEVIN C TANG | Director | Buy | 84,152.00 | 3.90 | 328,529.41 | 9,278,825.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120049871/0001209191-20-049871-index.htm |
| 2020-09-09 | KEVIN C TANG | Director | Buy | 48,296.00 | 4.01 | 193,893.95 | 9,327,121.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120049871/0001209191-20-049871-index.htm |
| 2020-09-09 | KEVIN C TANG | Director | Buy | 78,369.00 | 4.03 | 316,046.50 | 9,405,490.00 | https://www.sec.gov/Archives/edgar/data/920465/000120919120049871/0001209191-20-049871-index.htm |
| 2020-05-15 | Lakhmir S Chawla | Chief Medical Officer | Buy | 335.00 | 5.86 | 1,963.10 | 9,451.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000075/0000920465-20-000075-index.htm |
| 2020-03-31 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 459.00 | 3.57 | 1,638.63 | 9,470.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000046/0000920465-20-000046-index.htm |
| 2020-08-20 | DAVID A RAMSAY | Director | Buy | 3,470.00 | 4.17 | 14,469.90 | 9,470.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000137/0000920465-20-000137-index.htm |
| 2020-04-15 | Darryl Wellinghoff | Chief Commercial Officer | Buy | 34.00 | 5.61 | 190.74 | 9,504.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000050/0000920465-20-000050-index.htm |
| 2020-05-29 | Lakhmir S Chawla | Chief Medical Officer | Buy | 491.00 | 4.01 | 1,968.91 | 9,942.00 | https://www.sec.gov/Archives/edgar/data/920465/000092046520000082/0000920465-20-000082-index.htm |